Phoenix Tissue Repair, Inc.
Biotechnology ResearchMassachusetts, United States2-10 Employees
Phoenix Tissue Repair is advancing a novel treatment for Dystrophic Epidermolysis Bullosa (DEB), a rare skin disease resulting from a deficiency of human collagen type VII.